Gritstone bio Inc (NASDAQ:GRTS)
| 6.25 Delayed Data As of Jan 14 |  -0.05 / -0.79%Today’s Change | 5.90 Today|||52-Week Range 35.20 | -51.40% Year-to-Date |
Latest GRTS News | Press Releases
| Which Vaccine Stocks Will Make You a Fortune in 2022? Jan 12 / MotleyFool.com - Paid Partner Content | Are Options Traders Betting on a Big Move in Gritstone (GRTS) Stock? Jan 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.30 |
| Today’s open | 6.37 |
| Day’s range | 6.08 - 6.37 |
| Volume | 123,453 |
| Average volume (3 months) | 1,697,164 |
| Market cap | $424.9M |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | +0.98% |
| Earnings growth (this year) | +62.68% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -7.51% |
| P/E ratio | NM |
| Price/Sales | 36.88 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SPROSpero Therapeutics I... | +1.25 | +10.48% |
| ORMPOramed Pharmaceutica... | +0.08 | +0.73% |
| GTHXG1 Therapeutics Inc | +0.62 | +6.53% |
| VRDNViridian Therapeutic... | +0.98 | +5.16% |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$105.3M |
| Net profit margin | -2,608.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
